The pharmacological elimination of FasL or genetic suppression of the Fas–FasL system has been observed to exert a neuroprotective effect [14,26,27,28], highlighting the role of the Fas–FasL signaling cascade in the events leading to stroke-induced neuronal damage [29,30]. The gene discussed is FAS; the disease is Stroke.